Skip to content
    AI

    ARK Investment Management

    ARK Investment Management is a Series D to growth stage investment firm. It has made 4 investments. 40% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-d (40% of deals). Average disclosed round size is $166.3M (across 3 rounds with reported amounts).

    Find people at ARK Investment Management on Goldilocks AI

    Portfolio

    4

    Fund Size

    —

    Top Stage

    Series D

    Last 12 Mo

    0

    Team

    TK

    Tasha Keeney, CFA

    Director of Investment Analysis and Director of Research

    CW

    Cathie Wood

    Investment Professional

    DW

    Daniel White, CFA

    Portfolio Manager

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    Portfolio

    5 investments
    CompanyRoundAmountDate
    Neuralink logoNeuralinkSeries E—Jun 2025
    Lambda logoLambdaSeries E—Jan 2025
    Archer logoArcherSeries D$215MAug 2023
    Neuralink logoNeuralinkSeries D$280MJan 2023
    Sortium logoSortiumGrowth$4M—

    Top Co-Investors

    Last updated: 27 September 2026